Effect of vitamin D 3 on chemokine expression in pulmonary tuberculosis

Cytokine

Volumn 60, Issue 1, 2012, Pages 212-219

  Selvaraj, P ^a   Harishankar, M ^a   Singh, Brijendra ^a   Banurekha, V V ^b   Jawahar, M S ^b  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^b INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

Author keywords

Chemokines; Tuberculosis; Vitamin d 3

Indexed keywords

CHEMOKINE; COLECALCIFEROL; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOKINE; RANTES; BACTERIAL PROTEIN; CFP 10 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; CFP-10 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; VITAMIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREGULATION; LUNG TUBERCULOSIS; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; BLOOD; CELL CULTURE; DRUG EFFECT; GENETICS; METABOLISM; MONONUCLEAR CELL; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MYCOBACTERIUM TUBERCULOSIS;

ADULT; BACTERIAL PROTEINS; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINE CCL3; CHEMOKINE CCL4; CHEMOKINE CCL5; CHEMOKINE CXCL10; CHEMOKINE CXCL9; CHEMOKINES; CHOLECALCIFEROL; GENE EXPRESSION; HUMANS; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUBERCULOSIS, PULMONARY; VITAMINS; YOUNG ADULT;

EID: 84865408661     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.06.238     Document Type: Article

References (34)

1. Global tuberculosis control 2011. The burden of disease caused by TB. WHO Report; 2011.
2. Ellman P., Anderson K.H. Calciferol in tuberculous peritonitis with disseminated tuberculosis. Br Med J 1948, 1:394.
3. Chocano-Bedoya P., Ronnenberg A.G. Vitamin D and tuberculosis. Nutr Rev 2009, 67:289-293.
4. Mora J.R., Iwata M., von Andrian U.H. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 2008, 8:685-698.
5. Ohta M., Okabe T., Ozawa K., Urabe A., Takaku F. 1α,25-dihydroxyvitamin D3 (calcitriol) stimulates proliferation of human circulating monocytes in vitro. FEBS Lett 1985, 185:9-13.
6. Martineau A.R., Wilkinson K.A., Newton S.M., Floto R.A., Norman A.W., Skolimowska K., et al. IFN-gamma and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J Immunol 2007, 178:7190-7198.
7. Chandra G., Selvaraj P., Jawahar M.S., Banurekha V.V., Narayanan P.R. Effect of vitamin D3 on phagocytic potential of macrophages with live Mycobacterium tuberculosis and lymphoproliferative response in pulmonary tuberculosis. J Clin Immunol 2004, 24:249-257.
8. Vidyarani M., Selvaraj P., Jawahar M.S. Narayanan PR.1, 25 Dihydroxyvitamin D3 modulated cytokine response in pulmonary tuberculosis. Cytokine 2007, 40:128-134.
9. Prabhu Anand S., Selvaraj P., Narayanan P.R. Effect of 1,25 dihydroxyvitamin D3 on intracellular IFN-gamma and TNF-alpha positive T cell subsets in pulmonary tuberculosis. Cytokine 2009, 45:105-110.
10. Baggiolini M., Dewald B., Moser B. Human chemokines: an update. Annu Rev Immunol 1997, 15:675-705.
11. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000, 12:121-127.
12. Sadek M.I., Sada E., Toossi Z., Schwander S.K., Rich E.A. Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis. Am J Respir Cell Mol Biol 1998, 19:513-521.
13. Hasan Z., Cliff J.M., Dockrell H.M., Jamil B., Irfan M., Ashraf M., et al. CCL2 responses to mycobacterium tuberculosis are associated with disease severity in tuberculosis. PLoS One 2009, 4:e8459.
14. Chiu B.C., Freeman C.M., Stolberg V.R., Komuniecki E., Lincoln P.M., Kunkel S.L., et al. Cytokine-chemokine networks in experimental mycobacterial and schistosomal pulmonary granuloma formation. Am J Respir Cell Mol Biol 2003, 29:106-116.
15. 3 level and expression of Vitamin D receptor and cathelicidin in pulmonary tuberculosis. J Clin Immunol 2009, 29(4):470-478.
16. Wilkinson R.J., Llewelyn M., Toossi Z., Patel P., Pasvol G., Lalvani A., et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet 2000, 355:618-621.
17. Lemire J.M., Archer D.C., Beck L., Spiegelberg H.L. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J Nutr 1995, 125:1704S-1708S.
18. Muller K., Odum N., Bendtzen K. 1,25-dihydroxyvitamin D3 selectively reduces interleukin-2 levels and proliferation of human T cell lines in vitro. Immunol Lett 1993, 35:177-182.
19. Algood H.M., Chan J., Flynn J.L. Chemokines and tuberculosis. Cytokine Growth Factor Rev 2003, 14:467-477.
20. Mastroianni C.M., Lancella L., Mengoni F., Lichtner M., Santopadre P., D'Agostino C., et al. Chemokine profiles in the cerebrospinal fluid (CSF) during the course of pyogenic and tuberculous meningitis. Clin Exp Immunol 1998, 114:210-214.
21. Sharma S.K., Mitra D.K., Balamurugan A., Pandey R.M., Mehra N.K. Cytokine polarization in miliary and pleural tuberculosis. J Clin Immunol 2002, 22:345-352.
22. Kurashima K., Mukaida N., Fujimura M., Yasui M., Nakazumi Y., Matsuda T., et al. Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients. Am J Respir Crit Care Med 1997, 155:1474-1477.
23. Flores-Villanueva P.O., Ruiz-Morales J.A., Song C.H., Flores L.M., Jo E.K., Montano M., et al. A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. J Exp Med 2005, 202:1649-1658.
24. Qiu L., Huang D., Chen C.Y., Wang R., Shen L., Shen Y., et al. Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFNbeta, TIM1, and TLR2 but low antigen-specific cellular responses. J Infect Dis 2008, 198:1514-1519.
25. Means T.K., Golenbock D.T., Fenton M.J. The biology of Toll-like receptors. Cytokine Growth Factor Rev 2000, 11:219-232.
26. Foletta V.C., Segal D.H., Cohen D.R. Transcriptional regulation in the immune system: all roads lead to AP-1. J Leukoc Biol 1998, 63:139-152.
27. Kliewer S.A., Umesono K., Mangelsdorf D.J., Evans R.M. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature 1992, 355:446-449.
28. Moeenrezakhanlou A., Nandan D., Reiner N.E. Identification of a calcitriol regulated Sp-1 site in the promoter of human CD14 using a combined Western Blotting Electrophoresis Mobility Shift assay (WEMSA). Biol Proceed Online 2008, 10:29-35.
29. Cohen-Lahav M., Shany S., Tobvin D., Chaimovitz C., Douvdevani A. Vitamin D decreases NFkB activity by increasing IkBa levels. Nephrol Dial Transplant 2006, 21:889-897.
30. 3 and its analogs. J Biol Chem 2003, 278:49378-49385.
31. Griffin M.D., Xing N., Kumar R. Gene expression profiles in dendritic cells conditioned by 1alpha, 25-dihydroxyvitamin D3 analog. J Steroid Biochem Mol Biol 2004, 89-90:443-448.
32. 3 (tacalcitol). Br J Pharmacol 1998, 124:1433-1438.
33. Banerjee A., Damera G., Bhandare R., Gu S., Lopez-Boada Y.S., Panettieri R.A., et al. Vitamin and glucocorticoids differentially modulate chemokine expression in human airway smooth muscle cells. Brit J Pharmacol 2008, 155:84-92.
34. Casola A., Garofola R.P., Haeberle H., Elliot T.F., Lin R., Jamaluddin M., et al. Multiple Cis regulatory elements controls RANTES promoter activity in alveolar epithelial cells infected with respiratory syncytial virus. J Virol 2001, 75:6428-6439.